Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Outlook for PLTR Stock Neutral, After Recent Lawsuit Drama

PLTR stock has been in the limelight recently following a high-profile lawsuit the company faced over a U.K. contract with the NHS.

Here’s Why Bond Yields Really Are a Really Big Deal for QQQ Stock

Investors in QQQ stock should be wary of the impact bond yields could have on technology stocks in this overvalued market today.

Ripple Adds an Extra Layer of Risk That Just Isn’t Worth It Right Now

Here's the one key headwind XRP investors are facing right now, as the digital currency remains unlisted and investors want access.

New Concept Energy Could Be Poster Child for Meme Stock Hysteria

Investors in GBR stock experienced perhaps one of the most amazing peaks and valleys in some time. But New Concept Energy stands essentially as a shell company now.

7 NFT Crypto Plays for the Adventurous Investor’s Watch List

Investors looking for NFT crypto plays today certainly have quite a few options (some speculative, and some based in reality).

Nano Dimension Is a Small Cap Growth Play With Large Valuation

Investors in NNDM stock are appearing to lose patience with the company, as it struggles to put its cash to work amid valuation concerns.

The Case for GameStop Hitting $1,000 This Year

Those holding on with diamond hands could be rewarded with a $1,000 share price in GME stock in the near-term, but it won't last.

COMP Stock IPO: 9 Things to Know as Compass Starts Trading Today

Today, shares of COMP stock are soaring following the company's highly anticipated initial public offering as investors jump aboard.

UPC Stock: Why Universe Pharmaceuticals Is Popping Higher Today

Here's why UPC stock is surging today on news that a broker leading the deal exercised its over-allotment option, in a surprising move.

Asensus Surgical’s Name Has Changed, But Investors’ Valuation Concerns Haven’t

Investors may be well-served by having a look at this company's financials before buying TRXC stock.